# Apple Tree Partners

> Apple Tree Partners is a VC fund backing Biotechnology and Health Care. See 94 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 94
- Last investment: Aug 2024
- Lead investor: 64%
- Fund size: $1B
- Last fund: Dec 2020
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10264618
- X (Twitter): https://www.twitter.com/appletreepartners
- Website: http://www.appletreepartners.com

Apple Tree Partners is a VC fund in New York focused on Biotechnology and Health Care. ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategicinsight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.

## Contacts

5 contacts available for Apple Tree Partners. Shizune tracks 33 team members at Apple Tree Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/apple-tree-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.5M–$8M |
| Series A | $20M–$75M |
| Series B | $29M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 30 | 32% |
| Health Care | 23 | 24% |
| Therapeutics | 13 | 14% |
| Medical | 10 | 11% |
| Medical Device | 7 | 7% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 20 | 21% |
| Series B | 11 | 12% |
| Seed | 8 | 9% |
| Funding Round | 5 | 5% |
| Series C | 4 | 4% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 34 | 36% |
| Canada | 3 | 3% |
| United Kingdom | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexander McCampbell | Venture Partner | 0 | https://shizune.co/investors/profile/alexander-mccampbell |
| Andrew Bayliffe | Venture Partner | 2 | https://shizune.co/investors/profile/andrew-bayliffe |
| Anna Batarina | Partner | 0 | https://shizune.co/investors/profile/anna-batarina |
| Brian Vash | Entrepreneur in Residence | 0 | https://shizune.co/investors/profile/brian-vash |
| Daniel Finkelman | General Counsel | 0 | https://shizune.co/investors/profile/daniel-finkelman-9525 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Red Queen Therapeutics | Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial products while most focus on either medical or agricultural applications. | $55M | Series A | Aug 06, 2024 |  |
| Red Queen Therapeutics | Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial products while most focus on either medical or agricultural applications. | $55M | Series A | Aug 06, 2024 |  |
| Red Queen Therapeutics | Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial products while most focus on either medical or agricultural applications. | $55M | Series A | Aug 06, 2024 |  |
| Red Queen Therapeutics | Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial products while most focus on either medical or agricultural applications. | $55M | Series A | Aug 06, 2024 |  |
| Red Queen Therapeutics | Red Queen Therapeutics is a biotech company that works in the fields of medicine, agriculture, crop production, non-food use of crops, and heavy industry. They generally research, develop, and produce a variety of commercial products while most focus on either medical or agricultural applications. | $55M | Series A | Aug 06, 2024 |  |
| Deep Apple Therapeutics | Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen. | $52M | Series A | Dec 14, 2023 |  |
| Deep Apple Therapeutics | Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen. | $52M | Series A | Dec 14, 2023 |  |
| Deep Apple Therapeutics | Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen. | $52M | Series A | Dec 14, 2023 |  |
| Deep Apple Therapeutics | Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen. | $52M | Series A | Dec 14, 2023 |  |
| Deep Apple Therapeutics | Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen. | $52M | Series A | Dec 14, 2023 |  |

10 of 94 investments shown.

## Co-investors
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 8 deals together
- [NYU Langone Health](https://shizune.co/investors/profile/nyu-langone-health) — VC Fund, 6 deals together
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 5 deals together
- [Baxalta Ventures](https://shizune.co/investors/profile/baxalta-ventures) — VC Fund, 4 deals together
- [Excel Venture Management](https://shizune.co/investors/profile/excel-venture-management) — VC Fund, 4 deals together
- [Lilly Ventures](https://shizune.co/investors/profile/lilly-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Biotech Investors in United States](https://shizune.co/investors/biotech-investors-united-states)
- [Biotech VC Funds in United States](https://shizune.co/investors/biotech-vc-funds-united-states)
- [Life Science Investors in United States](https://shizune.co/investors/life-science-investors-united-states)
- [Life Science VC Funds in United States](https://shizune.co/investors/life-science-vc-funds-united-states)
- [Life Science VC Funds](https://shizune.co/investors/life-science-vc-funds)
- [Life Science Investors](https://shizune.co/investors/life-science-investors)

## FAQ

### What does Apple Tree Partners invest in?

Apple Tree Partners invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Series A and Series B stage. Most of the 94 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Apple Tree Partners's check size?

Apple Tree Partners typically joins rounds of $3.5M–$8M at Seed, $20M–$75M at Series A and $29M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Apple Tree Partners participates in.

### How do I contact Apple Tree Partners?

Public channels for Apple Tree Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Apple Tree Partners?

The team at Apple Tree Partners includes Alexander McCampbell (Venture Partner), Andrew Bayliffe (Venture Partner) and Anna Batarina (Partner), among 33 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co